News
By Reuters March 22, 201612:30 PM UTCUpdated ago March 22 (Reuters) - Biopharmx Corp * Received institutional review board (IRB) approval to initiate phase 4 study of Violet molecular iodine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback